Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Gutmann

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Biological Chemistry|April 29, 2015
The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain FoldSascha Gutmann, Alexandra Hinniger, Gabriele Fendrich, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Zécri, et al.
Journal of Medicinal Chemistry|August 10, 2016
Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase InhibitorsRalf Glatthar, Aleksandar Stojanovic, Thomas Troxler, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Stauffer, et al.
Journal of Medicinal Chemistry|February 22, 2020
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine KinaseDaniela Angst, François Gessier, Philipp Janser, et al.
Journal of Medicinal Chemistry|May 2, 2022
Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase InhibitorRobin A Fairhurst, Pascal Furet, Patricia Imbach-Weese, et al.
Cell|December 10, 2024
Dual BACH1 regulation by complementary SCF-type E3 ligasesBenedikt Goretzki, Maryam Khoshouei, Martin Schröder, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 InhibitorAlexei S Karpov, Payman Amiri, Cornelia Bellamacina, et al.
Nature Communications|December 3, 2025
Development of a p62 biodegrader for autophagy targeted degradationZacharias Thiel, David Marcellin, Carole Manneville, et al.
Nature Communications|April 27, 2021
PAX8 and MECOM are interaction partners driving ovarian cancerMelusine Bleu, Fanny Mermet-Meillon, Verena Apfel, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Biological Chemistry|April 29, 2015
The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain FoldSascha Gutmann, Alexandra Hinniger, Gabriele Fendrich, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Zécri, et al.
Journal of Medicinal Chemistry|August 10, 2016
Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase InhibitorsRalf Glatthar, Aleksandar Stojanovic, Thomas Troxler, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Stauffer, et al.
Journal of Medicinal Chemistry|February 22, 2020
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine KinaseDaniela Angst, François Gessier, Philipp Janser, et al.
Journal of Medicinal Chemistry|May 2, 2022
Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase InhibitorRobin A Fairhurst, Pascal Furet, Patricia Imbach-Weese, et al.
Cell|December 10, 2024
Dual BACH1 regulation by complementary SCF-type E3 ligasesBenedikt Goretzki, Maryam Khoshouei, Martin Schröder, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 InhibitorAlexei S Karpov, Payman Amiri, Cornelia Bellamacina, et al.
Nature Communications|December 3, 2025
Development of a p62 biodegrader for autophagy targeted degradationZacharias Thiel, David Marcellin, Carole Manneville, et al.
Nature Communications|April 27, 2021
PAX8 and MECOM are interaction partners driving ovarian cancerMelusine Bleu, Fanny Mermet-Meillon, Verena Apfel, et al.
Pageof 2